Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Closing Bell: Sensex falls 144 pts, Nifty manages to hold 10,500; PSU banks drag

2018-02-14 moneycontrol
The 30-share BSE Sensex was down 144.52 points at 34,155.95 and the 50-share NSE Nifty declined 38.90 points to 10,500.90. (17-0)

Market Live: Sensex ranged, midcaps continue to shine; RIL, HDFC twins support

2018-02-14 moneycontrol
2:15 pm Results Reaction: Dhanuka Agritech and Gateway Distriparks shares declined 1 percent each after weak operational performance. (15-0)

NRB Bearings, Aarti Drugs up 7% on strong Q3 numbers

2018-02-14 moneycontrol
Shares of NRB Bearings and Aarti Drugs rose more than 7 percent intraday Wednesday on the back of strong third quarter results.

What to Watch - SJVN, Aarti Drugs: Buyback offers open

2018-02-12 thehindubusinessline
The buyback offers of SJVN and Aarti Drugs will open on Thursday and close on February 28.The Centre has approved a buyback of 20.68 crore shares or 5 per cent stake of SJVN for over ₹801 crore at ₹38.75 a share.

Aarti Drugs Limited - Results

2018-02-06 nseindia

Aarti Drugs Limited - Trading Window

2018-02-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Buyback: Aarti Drugs, Orbit Exports ex-date

2018-01-16 thehindubusinessline
Shares of Aarti Drugs and Orbit Exports will remain in focus on Wednesday, as they turn ex-date for the proposed buyback. Aarti Drugs will buy back up to 2.75 lakh shares, representing up to 1.15 per cent stake of the paid-up capital, at ₹875 a share; Orbit Exports’ buy-back of up to 4.44 lakh shares (representing 1.55 per cent stake) would be at a price of ₹180 a share. Both the buyback offers would be on proportionate basis, through the tender offer route.

Aarti Drugs Limited - Public Announcement - Buyback of Shares

2018-01-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Aarti Drugs Limited - Public Announcement - Buyback of Shares

2018-01-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Aarti Drugs rises 7% on buyback approval

2018-01-09 moneycontrol
Shares of Aarti Drugs touched 52-week high of Rs 784.80, rising 7 percent in the early trade on Tuesday on approval of buyback of shares.

Market Live: Sensex, Nifty, Midcap off record highs; Coal India extends gains

2018-01-09 moneycontrol
9:55 am Buzzing: Shares of Aarti Drugs touched 52-week high of Rs 784.80, rising 7 percent in the early trade on approval of buyback of shares. (26-0)

Aarti Drugs Limited - Outcome of Board Meeting

2018-01-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Aarti Drugs Limited - Record Date

2018-01-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Aarti Drugs Limited - Buyback

2018-01-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Trade setup for Monday: Top 15 things you should know before Opening Bell

2018-01-08 moneycontrol
Indian markets hit a fresh record closing high to sign off the week on a bullish note. The index rose 0.27 percent for the week ended January 5. The Nifty made a small bullish candle on the daily candlestick charts and a Hanging Man kind of patterns on the weekly charts. (2-0)